Biotechnology Entity > ABOUT MJ > FOUR ENTITIES > Biotechnology Entity
 
Believing that Prevention is better than Cure, MJ has devoted substantial resources to the promotion of preventive care. It uses a large-scale human biological database to develop disease prediction models and examine the associated risk factors. The company is also committed to providing comprehensive access of such data to the biomedical industry in order to further facilitate its innovation in areas ranging from health screening to disease diagnosis. Also, by detecting signs of disease at the data level, MJ hopes to identify health risks at an early stage and develop optimal treatment plans for the customers, helping them achieve better health management and essentially improve their quality of life. This is why MJ has had such a long-standing involvement in R&D partnerships with academic research institutes worldwide, and will continue its search for breakthrough solutions to address issues in the biotech industry.
Division Composition
The MJ Health Research Foundation